
Restrictions on mailing the abortion drug mifepristone were allowed to take effect by the Supreme Court after an appeals-court order narrowed telehealth and pharmacy distribution, creating uneven availability. NPR’s overview places that decision alongside state law changes and clinic closures, emphasizing how mail and telemedicine rulings have become a central fault line in post-Dobbs access.
Click a connection line between nodes to view confidence and evidence.